Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.91%
#2 Cysic Cysic +7.96%
#3 Palladium Network Palladium Network +6.82%
#4 Akedo Akedo +4.46%
#5 KOTAI KOTAI +2.16%
#6 DOVU DOVU +2.01%
#7 BOOK OF MEME BOOK OF MEME +1.65%
#8 Orochi Network Orochi Network +1.51%
#9 DoubleZero DoubleZero +1.40%
#10 Fartcoin Fartcoin +1.35%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Synairgen plc Synairgen plc

Synairgen plc

SNG
Rankning i aktier #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Aktiekurs
$0.01292666
Senast synkroniserad: 2025-04-08
Marknadsvärde
$157.54K
Förändring (1 dag)
6.84%
Förändring (1 år)
0.00%
Land
GB
Handel Synairgen plc (SNG)

Kategori

Healthcare
Antal utestående aktier för Synairgen plc (SNG)
Antal utestående aktier per June 2024: 201.38M
Enligt de senaste finansiella rapporterna och aktiekursen för Synairgen plc är det aktuella antalet utestående aktier 201.38M. I slutet av December 2022 hade företaget 201.36M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Synairgen plc (SNG) från 2004 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 201.38M 0.00%
2023 201.38M 0.01%
2022 201.36M 0.46%
2021 200.44M 36.24%
2020 147.12M 33.64%
2019 110.09M 15.56%
2018 95.26M 1.15%
2017 94.18M 2.48%
2016 91.90M 0.64%
2015 91.32M 3.77%
2014 88.00M 16.35%
2013 75.64M 4.37%
2012 72.47M 19.66%
2011 60.56M 0.77%
2010 60.10M 154.94%
2009 23.57M 8.03%
2008 21.82M -9.98%
2007 24.24M 1.94%
2006 23.78M 26.20%
2005 18.84M 85.90%
2004 10.14M 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 26.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -69.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE